Geron | GERN - Selling And Administration Expenses

Stock Price
1.58
Daily Change
-0.02 -1.25%
Monthly
-12.22%
Yearly
-3.66%
Q1 Forecast
1.53

Geron reported $41.67M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Amgen USD 1.94B 237M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
Cassava Sciences USD 7.9M 1.08M Sep/2025
Cytokinetics USD 91.72M 67.02M Dec/2025
Esperion Therapeutics USD 39.98M 4.21M Sep/2024
Exelixis USD 123.02M 19.9M Dec/2025
Genmab DKK 144M 18M Jun/2025
Geron USD 41.67M 2.67M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
Incyte USD 390.41M 61.33M Dec/2025
MacroGenics USD 9.9M 600K Sep/2025
Novartis USD 3.31B 134M Sep/2025
Novavax USD 66.95M 34.05M Sep/2024